Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Medigene AG

Start price
Target price
Perf. (%)
€2.05
03.01.23
-
03.01.24
-14.63%
26.04.23

buy
Paion AG

Start price
Target price
Perf. (%)
€0.51
03.01.23
-
03.01.24
33.60%
26.04.23

buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€326.00
04.04.22
-
04.04.23
-31.60%
05.04.23

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.79
22.02.22
€4.00
22.02.23
-45.05%
23.02.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
MagForce AG

Start price
Target price
Perf. (%)
€2.37
29.01.22
€2.80
29.01.23
-99.48%
30.01.23

Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€43.10
09.01.23
-
09.01.24
-0.35%
21.01.23

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€38.00
09.01.23
-
09.01.24
-1.05%
21.01.23

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€90.00
12.01.22
-
12.01.23
-44.82%
13.01.23

MagForce AG

Start price
Target price
Perf. (%)
€2.87
15.12.21
-
15.12.22
-99.93%
16.12.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
High valuation
Risky balance sheet
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.60
06.12.21
€2.80
06.12.22
-1.25%
07.12.22

Could be worthwhile Investment >10% per year
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.03
29.11.21
-
29.11.22
-21.12%
30.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€59.95
27.11.21
€75.00
27.11.22
-29.44%
28.11.22

Could be very worthwhile Investment >20% year
Few uniques
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Biotest AG VZ

Start price
Target price
Perf. (%)
€39.50
19.11.21
-
19.11.22
-12.15%
20.11.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
buy
Paion AG

Start price
Target price
Perf. (%)
€1.23
27.12.21
€2.00
27.12.22
-26.75%
08.09.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€98.65
04.01.22
-
04.01.23
-56.84%
25.08.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.73%
25.08.22

buy
Mevis Medical Sol.na

Start price
Target price
Perf. (%)
€30.80
23.12.21
-
23.12.22
3.25%
25.08.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.56
23.12.21
-
23.12.22
-18.27%
25.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€126.20
24.08.21
-
24.08.22
-67.27%
24.08.22

buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€27.00
06.08.21
-
06.08.22
-38.33%
06.08.22

Stratec SE

Start price
Target price
Perf. (%)
€85.00
26.07.22
€66.00
26.07.23
4.94%
06.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€77.90
08.07.21
-
08.07.22
-46.53%
08.07.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€117.40
08.07.21
-
08.07.22
-19.51%
08.07.22